Purity Peps
Amount per vial:
20 mg
Vial count:
1 vial

Retatrutide 20 mg

In stock

Amount per vial (mg)

Specifications
Amount per vial20 mg
Vial count1 vial
Documentation

Submitted laboratory report

Laboratory
Janoshik (as stated on submitted report)
Task
#244482
Batch
021026
Analysis date
2026-10-30
Reported mass
19.08 mg
Reported purity
99.749%

Report image awaiting upload

Results are from submitted documentation and have not been independently confirmed.

View in COA Library

Documentation enquiry

Ask about documentation
About & regulatory status

Triple GIP / GLP-1 / glucagon receptor agonist (LY3437943)

Informational profile of an investigational triple-receptor agonist. The 20 mg designation is a catalogue size reference, not a dosing recommendation. Long-term safety data remain incomplete.

Regulatory status: Investigational — not authorized for consumer sale in Canada. Not an approved medicine. This entry is informational only and is not offered for sale.

FAQ

Is this product for sale?

No. This page is research information only. There is no ordering, cart or payment on this site.

Is a certificate of analysis available?

No certificate of analysis is published. Where a laboratory report has been submitted, its figures are listed in the Documentation section exactly as stated and are not independently confirmed. You may ask about documentation; availability is not guaranteed.

Is dosing information provided?

No. Purity Peps does not provide dosing, preparation or administration instructions.

Which specifications are shown?

Only supplied and confirmed specifications are shown. Nothing is inferred from imagery or packaging concepts.